RE: Hey up16 Jun 2020 19:18
sax
the scientific information for clevegen, 90 percent was over my head. [not sure if that was the general feeling]
one takeout for me was that they are accelerating the program which i assume is why marku said we should see shareholder value added in the time frame indicated
juho spoke on traumakine which was very interesting
my take out from that is we should see results from who solidarity and remap sooner than expected. i think he sid anyday now something will drop in our lap
he said that interferon beta 1a iv intravenous ws the who fist choice of delivery for the drug
he said Iran medics have published a paper but not yet submitted for peer review taht he desgribed them as doing their homework and haven't given interferon bet with steroids and have seen good results.
he said who knows who lap this report will fall in
as i mentioned in another post he was like we have been on the ArDs case for 10 years, we know what we are doing and he put interferon in the middle of all the other drugs they are looking in trials as the no1 choice for treating ards also covid
mentioned there is a world shortage of interferon beta 1a which makes sence we have the 2.1 million loan to start manufacturing [on this my own thoughts are we could make traumakine and the raw ingredients for other companies]
and he mentioned fast track of traumakine.
all in all we seem to be going from strength to strength with both drugs and i the recent cash injections from grants, loans ect..